In today's Pharmaceutical Executive Daily, a new analysis finds that TrumpRx is listing prices for roughly a third of its featured drugs higher than what patients in the United Kingdom pay, two ...

Reuters benchmarking versus UK NHS payouts showed ~33% of sampled TrumpRx-listed drugs were cheaper in the UK, with 67%–82% ...

Chief manufacturing officers must treat slow tech transfer and CDMO onboarding as a strategic liability, given patent cliffs, modality complexity, and China+1 diversification pressures. Agentic AI and ...

Mad Money' host Jim Cramer looks at a buying opportunity in a winning pharmaceutical stock amid market turmoil.

As industries like pharmaceuticals, energy storage, and specialty chemicals continue to expand, the need for precise, high-performance powder processing equipment becomes even more critical. In the ...

POTOMAC, MD / ACCESS Newswire / March 18, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company developing therapeutics for Alzheimer's disease, ...

In a call hosted recently, Nasus Pharma (NYSE:NSRX) presented strong positive topline results from its Phase 2 clinical study ...

National Institutes of Health-funded research center aims to strengthen chemical safety assessments and reduce animal-based evaluations ...

BioSyent Inc. ('BioSyent”, TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2025. Key highlights include: ...

The Relist Watch column examines cert petitions that the Supreme Court has “relisted” for its upcoming conference. A short explanation of relists is available here. There are 261 petitions and ...

RBC Capital Markets has compiled a list of 13 biotechs that are most likely to receive takeover interest, including Revolution Medicines (RVMD), Ascendis Pharma (ASND), and Arrowhead Pharma (ARWR), ...

Gabelli Funds Annual Specialty Chemicals Symposium March 19, 2026 1:30 PM EDTCompany ParticipantsWilliam Whitaker - Senior VP, CFO ...